ATE113940T1 - Aminobenzolsulfonsäurederivate. - Google Patents

Aminobenzolsulfonsäurederivate.

Info

Publication number
ATE113940T1
ATE113940T1 AT90400795T AT90400795T ATE113940T1 AT E113940 T1 ATE113940 T1 AT E113940T1 AT 90400795 T AT90400795 T AT 90400795T AT 90400795 T AT90400795 T AT 90400795T AT E113940 T1 ATE113940 T1 AT E113940T1
Authority
AT
Austria
Prior art keywords
group
sulfonic acid
acid derivatives
aminobenzene sulfonic
alkyl group
Prior art date
Application number
AT90400795T
Other languages
English (en)
Inventor
Hiromi Okushima
Akihiro Narimatsu
Makio Kobayashi
Naoya Satoh
Miyuki Morita
Original Assignee
Mitsubishi Chem Ind
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mitsubishi Chem Ind filed Critical Mitsubishi Chem Ind
Application granted granted Critical
Publication of ATE113940T1 publication Critical patent/ATE113940T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT90400795T 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate. ATE113940T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP7468489 1989-03-27
JP2064811A JPH0686438B2 (ja) 1989-03-27 1990-03-15 アミノベンゼンスルホン酸誘導体

Publications (1)

Publication Number Publication Date
ATE113940T1 true ATE113940T1 (de) 1994-11-15

Family

ID=26405909

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90400795T ATE113940T1 (de) 1989-03-27 1990-03-22 Aminobenzolsulfonsäurederivate.

Country Status (7)

Country Link
EP (1) EP0390654B1 (de)
JP (1) JPH0686438B2 (de)
AT (1) ATE113940T1 (de)
CA (1) CA2013037C (de)
DE (1) DE69013959T2 (de)
DK (1) DK0390654T3 (de)
ES (1) ES2063300T3 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2192731C (en) 1995-12-15 2005-09-27 Chika Yamazaki Monohydrates of aminobenzenesulfonic acid derivatives and method for preparing thereof
AU2446297A (en) * 1996-04-30 1997-11-19 Warner-Lambert Company Substituted piperazines and piperidines as central nervous system agents
US5859246A (en) * 1997-01-30 1999-01-12 Neurogen Corporation 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands
CN1109677C (zh) * 1997-06-13 2003-05-28 三菱化学株式会社 氨基苯磺酸衍生物的单水合物及其制备方法
US6407113B1 (en) 1998-02-12 2002-06-18 Mitsubishi Chemical Corporation Medicament for treatment of diastolic dysfunction
JP4635339B2 (ja) * 1998-02-12 2011-02-23 三菱化学株式会社 心拡張障害治療剤
DE60016803T2 (de) 1999-12-21 2005-12-29 Mitsubishi Pharma Corp. Heilmittel und/oder prophylactische mittel zur behandlung von nervensystem-störungen
US6569861B2 (en) 2000-07-06 2003-05-27 Neurogen Corporation Melanin concentrating hormone receptor ligands
US20050124632A1 (en) * 2001-03-13 2005-06-09 Yoshimi Kitada Remedies and/or preventives for diabetic ischemic heart diseases
IL158941A0 (en) 2001-05-22 2004-05-12 Neurogen Corp Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
AR034887A1 (es) * 2001-07-25 2004-03-24 Mitsubishi Pharma Corp Medicamento inhibidor del sistema de intercambio sodio/calcio
WO2003011296A1 (fr) * 2001-07-30 2003-02-13 Mitsubishi Pharma Corporation Preparations pharmaceutiques stables contenant comme principe actif des derives de l'acide aminobenzenesulphonique
JPWO2004019946A1 (ja) * 2002-08-30 2005-12-15 三菱ウェルファーマ株式会社 細胞内ナトリウムイオン過蓄積抑制薬
JPWO2004022545A1 (ja) * 2002-09-06 2005-12-22 三菱ウェルファーマ株式会社 移植臓器保護剤
WO2004069275A1 (ja) * 2003-02-04 2004-08-19 Mitsubishi Pharma Corporation 眼科用剤
CA2557262A1 (en) * 2004-03-05 2005-09-15 Mitsubishi Pharma Corporation Medicament for preventing and/or treating ischemic cardiovascular disease
WO2005110982A2 (en) 2004-04-07 2005-11-24 Neurogen Corporation Substituted 1-benzyl-4-substituted piperazine analogues
US20090318461A1 (en) 2006-07-21 2009-12-24 Chika Ohno Crystalline polymorphism of 5-methyl-2-(piperazin-1-yl) benzenesulfonic acid
JPWO2008010567A1 (ja) * 2006-07-21 2009-12-17 田辺三菱製薬株式会社 ５−メチル‐２‐（ピペラジン−１−イル）ベンゼンスルホン酸の塩形態又は溶媒和物
WO2008032814A1 (en) * 2006-09-14 2008-03-20 Mitsubishi Tanabe Pharma Corporation Aspirin-containing pharmaceutical agent
CN102782562B (zh) 2010-04-30 2015-07-22 北京理工大学 宽视场高分辨率拼接式头盔显示装置
TW202606680A (zh) * 2024-06-28 2026-02-16 日商田邊三菱製藥股份有限公司 角化症用醫藥組成物及其用途
JP7810867B1 (ja) * 2024-06-28 2026-02-03 田辺ファーマ株式会社 ヘイリーヘイリー病用医薬組成物およびその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1104514B (de) * 1955-06-29 1961-04-13 Parke Davis & Co Verfahren zur Herstellung von blutdrucksenkend wirkenden 1-Mercaptophenyl-4-piperazino-alkoholen
DE2040279A1 (de) * 1970-08-13 1972-02-17 Hoechst Ag Verfahren zur Herstellung basisch substituierter Benzolsulfonamide
DE2111811A1 (de) * 1971-03-12 1972-09-14 Hoechst Ag Basisch substituierte Benzolsulfonylformamidine und Verfahren zu ihrer Herstellung
DE3715763A1 (de) * 1987-05-12 1988-11-24 Hoechst Ag Diarylalkyl-substituierte alkylamine, verfahren zu ihrer herstellung, ihre verwendung sowie sie enthaltende arzneimittel

Also Published As

Publication number Publication date
ES2063300T3 (es) 1995-01-01
EP0390654A1 (de) 1990-10-03
JPH037263A (ja) 1991-01-14
EP0390654B1 (de) 1994-11-09
JPH0686438B2 (ja) 1994-11-02
CA2013037A1 (en) 1990-09-27
CA2013037C (en) 1999-12-07
DE69013959D1 (de) 1994-12-15
DE69013959T2 (de) 1995-03-16
DK0390654T3 (da) 1995-04-03

Similar Documents

Publication Publication Date Title
DE69013959D1 (de) Aminobenzolsulfonsäurederivate.
DK0850926T3 (da) Difluorprostaglandinderivater og deres anvendelse
NO308739B1 (no) Imidazolderivater samt medisinsk sammensetning og anti-HIV- sammensetning omfattende samme
DK0490566T3 (da) Fremstilling og anvendelse af N-iodpropargyloxycarbonylaminosyreestere og derivater som antimikrobielle midler
PT918776E (pt) Sintese total de acilfulvenos antitumorais
MX9100227A (es) Derivados de cefalosporina y procedimiento para su preparacion.
FI914187A0 (fi) Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta
TW352383B (en) Hydroximic acid derivatives, processes for their preparation, and compositions comprising them
AU6158486A (en) Dihydro pyridine derivatives
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
MX11866A (es) Nuevas cicloalquilamidas y procedimiento para su preparacion.
AU623500B2 (en) Carboxylimino benzothiazole derivatives
DK0812835T3 (da) Optisk aktive thiazolidinonderivater
ATE112769T1 (de) Benzoxazepinderivate.
ES2032214T3 (es) Un procedimiento para la preparacion de un derivado de ergolina.
DE3889993D1 (de) 2'-Deoxy-5-fluorouridin-Derivate.
FR2694557B1 (fr) Dérivés de tétrahydronaphtalène, leur préparation, et leur application en thérapeutique.
FI900973A0 (fi) Menetelmä valmistaa 2,3,4,5-tetrahydro-5-metyyli-1-/(5-metyyli-1H-imidatsol-4-yyli)-metyyli)/-1H-pyrido/4,3-b/-indol-1-onia
BR9305092A (pt) Processo para a preparação de derivados de 5-pirazolmercáptan, composto ditiocarbazato de etilideno, processo para a preparação de derivados do mesmo

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name
EELA Cancelled due to lapse of time